Advertisement

Pharmaceutisch Weekblad

, Volume 10, Issue 5, pp 207–212 | Cite as

Effect of cyclodextrins on anthracycline stability in acidic aqueous media

  • O. Bekers
  • J. H. Beijnen
  • E. H. Groot Bramel
  • M. Otagiri
  • W. J. M. Underberg
Original Articles

Abstract

The effect of cyclodextrins on the stability of six anthracyclines in acidic medium at 50°C has been investigated using a stability-indicating high pressure liquid Chromatographic method. The influences of various parameters, such as the structure of cyclodextrins (α-cyclodextrin, β-cyclodextrin, dimethyl-β-cyclodextrin and γ-cyclodextrin) and anthracyclines, cyclodextrin concentration, the pH and the presence of a co-solvent, are investigated. Lineweaver-Burk plots were used to calculate the stability constants of the various inclusion complexes as well as the rate constants for degradation of the anthracycline guest molecules in the complexes with the host cyclodextrins. Anthracyclines complexate only with γ-cyclodextrin to a substantial extent. On complexation the stability of the guest molecule increases, however, the degradation pattern does not alter. The influence of the pH on the degradation of the included molecule is identical to that of the free drug. Addition of co-solvents, such as acetonitrile, causes decomposition of the complex.

Keywords

Anthracyclines Chromatography high pressure liquid Cyclodextrins Drug stability 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Crooke ST, Reich SD. Anthracyclines: current status and new developments. New York: Academic Press, 1980.Google Scholar
  2. 2.
    Arcamone F. Antitumor anthracyclines: recent developments. Med Res Rev 1984;4:153–88.PubMedGoogle Scholar
  3. 3.
    Wasserman K, Bundgaard H. Kinetics of the acidcatalysed hydrolysis of doxorubicin. Int J Pharm 1983;14:73–8.Google Scholar
  4. 4.
    Beijnen JH, Wiese G, Underberg WJM. Aspects of the chemical stability of doxorubicin and seven other anthracyclines in acidic solution. Pharm Weekbl [Sci] 1985;7:109–16.Google Scholar
  5. 5.
    Davignon JP, Cradock JC. Pharmaceutical aspects of antitumour agents. Pharm Weekbl 1984;119:1144–50.Google Scholar
  6. 6.
    McLafferty DF, Woolfson AD, Launchburg AP. Stability of temazepam in parenteral formulations. Int J Pharm 1986;31:9–13.Google Scholar
  7. 7.
    Janssen MJH, Crommelin DJA, Storm G, Hulshoff A. Doxorubicin decomposition on storage. Effect of pH, type of buffer and liposome encapsulation. Int J Pharm 1985;23:1–11.Google Scholar
  8. 8.
    Herman EH, Rahman A, Ferrans VJ, Vick JA, Schein PS. Prevention of chronic doxorubicin cardiotoxicity in Beagles by liposomal encapsulation. Cancer Res 1983;43:5427–32.PubMedGoogle Scholar
  9. 9.
    Frank SG. Inclusion compounds. J Pharm Sci 1975;64:1585–604.PubMedGoogle Scholar
  10. 10.
    Szejtli J, ed. Proceedings of the first international symposium on cyclodextrins, Budapest, 1981. Dordrecht: D. Reidel Publishers, 1982.Google Scholar
  11. 11.
    Uekama K, Otagiri M. Cyclodextrins in drug carrier systems. Gr Rev Ther Drug Carrier Syst 1987;3:1–40.Google Scholar
  12. 12.
    Jones SP, Grant DJW, Hadgraft J, Parr GD. Cyclodextrins in the pharmaceutical sciences. Part 1: preparation, structure and properties of cyclodextrins and cyclodextrin inclusion compounds. Acta Pharm Technol 1984; 30: 213–23.Google Scholar
  13. 13.
    Jones SP, Grant DJW, Hadgraft J, Parr GD. Cyclodex-trins in the pharmaceutical sciences. Part 11: pharmaceutical, biopharmaceutical, biological and analytical aspects, and applications of cyclodextrin and its inclusion compounds. Acta Pharm Technol 1984;30:263–77.Google Scholar
  14. 14.
    Andersen FM, Bundgaard H. Inclusion complexation of metronidazole benzoate with β-cyclodextrin and its depression of anhydrate-hydrate transition in aqueous suspension. Int J Pharm 1984;19:189–97.Google Scholar
  15. 15.
    Uekama K. Inclusion complexes of cyclodextrins with organic drug molecules. Jpn J Antibiot 1979;32:103–11.Google Scholar
  16. 16.
    Lengyel MT, Szejtli J. Menadione-γ-cyclodextrin inclusion complex. J Incl Phenom 1985;3:1–18.Google Scholar
  17. 17.
    Kikuchi M, Uemura Y, Hirayama F, Otagiri M, Uekama K. Improvement of some pharmaceutical properties of carmoful by cyclodextrin complexation. J Incl Phenom 1984;2:623–30.Google Scholar
  18. 18.
    Uekama K, Hirayama F, Irie T. The new method for determination of the stability constants of cyclodextrinprostaglandin inclusion complexes by liquid chromatography. Chem Lett 1978:661–64.Google Scholar
  19. 19.
    Griffiths DW, Bender ML. Cycloamyloses as catalysts. Adv Catal 1973;23:209–63.Google Scholar
  20. 20.
    Andersen FM, Bundgaard H. The influence of β- cyclodextrin on the stability of hydrocortisone in aqueous solution. Arch Pharm Chem [Sci] 1983;11:61–6.Google Scholar
  21. 21.
    Andersen FM, Bundgaard H. The influence of cyclodextrin complexation on the stability of betamethason-17-valerate. Int J Pharm 1984;20:155–62.Google Scholar
  22. 22.
    Bates RG. Determination of pH. Theory and practice. 2nd ed. New York: John Wiley & Sons, 1973.Google Scholar
  23. 23.
    Tomlimson E, Malspeis L. Concomitant adsorption and stability of some anthracycline antibiotics. J Pharm Sci 1982;71:1121–5.PubMedGoogle Scholar
  24. 24.
    Uekama K. Pharmaceutical applications of methylated cyclodextrins. Pharm Int 1985;6:61–5.Google Scholar
  25. 25.
    Martin AN, Swarbrick J, Cammarata A. Physical pharmacy. Philadelphia: Lea & Fegiber, 1969.Google Scholar
  26. 26.
    Bender ML, Homigama M. Cyclodextrin chemistry. Berlin: Springer-Verlag, 1978.Google Scholar

Copyright information

© Bohn, Scheltema & Holkema 1988

Authors and Affiliations

  • O. Bekers
    • 1
  • J. H. Beijnen
    • 2
  • E. H. Groot Bramel
    • 1
  • M. Otagiri
    • 3
  • W. J. M. Underberg
    • 1
  1. 1.Department of Pharmaceutical Analysis, Faculty of PharmacyState University of UtrechtUtrechtthe Netherlands
  2. 2.Slotervaart Hospital/Netherlands Cancer InstituteAmsterdamthe Netherlands
  3. 3.Department of PharmaceuticsKumamoto UniversityKumamotoJapan

Personalised recommendations